The beneficial effects of probiotics on patients with coronary heart disease: a systematic review and meta-analysis

BackgroundCoronary heart disease (CHD) is a major global health burden, and emerging evidence suggested that probiotics could improve cardiovascular health by modulating gut microbiota and lipid profiles. However, the efficacy of probiotics remains elusive, indicating the necessity of conducting thi...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Dong, Lei Chen, Nan Zheng, Ming Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2025.1612021/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849422778072039424
author Jie Dong
Lei Chen
Nan Zheng
Ming Yang
author_facet Jie Dong
Lei Chen
Nan Zheng
Ming Yang
author_sort Jie Dong
collection DOAJ
description BackgroundCoronary heart disease (CHD) is a major global health burden, and emerging evidence suggested that probiotics could improve cardiovascular health by modulating gut microbiota and lipid profiles. However, the efficacy of probiotics remains elusive, indicating the necessity of conducting this meta-analysis.MethodsThis study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, searching PubMed, EMBASE, and Web of Science databases for retrieving randomized controlled trials (RCTs) on probiotics’ effects on lipid profiles (low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides (TG)) in CHD patients. Inclusion and exclusion criteria concentrated on English-language RCTs, and data on study characteristics were extracted. Study quality was assessed using Cochrane and NHLBI tools, and statistical analysis was conducted via R 4.3.2 software.ResultsThe literature search identified 263 records, yielding 6 RCTs, 5 of which were included in the meta-analyses. For LDL level (n = 278), both fixed-effects and random-effects models exhibited an overall effect size of 1.25 units [95% confidence interval (CI): −0.62 to 3.12] with a low heterogeneity (I2 = 0%), while probiotics-based monotherapy achieved a mean difference (MD) of 13.4105 (95% CI: −8.0670 to 34.8879) versus an MD of 1.1578 for combination therapy (95% CI: −0.7146 to 3.0302). For HDL level (n = 278), the fixed-effects model yielded an MD of −3.8107 (95% CI: −4.2490 to −3.3724) versus an MD of −2.3119 for the random-effects model (95% CI: −4.2290 to −0.3949) with a moderate heterogeneity (I2 = 61.6%). Combination therapy demonstrated an MD of −2.9848 (95% CI: −4.7965 to −1.1732), while monotherapy exhibited a non-significant MD of 0.9115 (95% CI: −3.5084 to 5.3314). TG analysis yielded a common effect size of 17.95, with a minimal-to-moderate heterogeneity (I2 = 0 to 84.7%).ConclusionProbiotics, particularly monotherapy for LDL and combination therapy for HDL, exhibited potential to improve lipid profiles in CHD patients. However, further research is needed to address existing limitations and confirm efficacy.
format Article
id doaj-art-f54e4d6102584dc69cc8e35e45ff87ae
institution Kabale University
issn 2296-861X
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj-art-f54e4d6102584dc69cc8e35e45ff87ae2025-08-20T03:30:56ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2025-06-011210.3389/fnut.2025.16120211612021The beneficial effects of probiotics on patients with coronary heart disease: a systematic review and meta-analysisJie DongLei ChenNan ZhengMing YangBackgroundCoronary heart disease (CHD) is a major global health burden, and emerging evidence suggested that probiotics could improve cardiovascular health by modulating gut microbiota and lipid profiles. However, the efficacy of probiotics remains elusive, indicating the necessity of conducting this meta-analysis.MethodsThis study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, searching PubMed, EMBASE, and Web of Science databases for retrieving randomized controlled trials (RCTs) on probiotics’ effects on lipid profiles (low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides (TG)) in CHD patients. Inclusion and exclusion criteria concentrated on English-language RCTs, and data on study characteristics were extracted. Study quality was assessed using Cochrane and NHLBI tools, and statistical analysis was conducted via R 4.3.2 software.ResultsThe literature search identified 263 records, yielding 6 RCTs, 5 of which were included in the meta-analyses. For LDL level (n = 278), both fixed-effects and random-effects models exhibited an overall effect size of 1.25 units [95% confidence interval (CI): −0.62 to 3.12] with a low heterogeneity (I2 = 0%), while probiotics-based monotherapy achieved a mean difference (MD) of 13.4105 (95% CI: −8.0670 to 34.8879) versus an MD of 1.1578 for combination therapy (95% CI: −0.7146 to 3.0302). For HDL level (n = 278), the fixed-effects model yielded an MD of −3.8107 (95% CI: −4.2490 to −3.3724) versus an MD of −2.3119 for the random-effects model (95% CI: −4.2290 to −0.3949) with a moderate heterogeneity (I2 = 61.6%). Combination therapy demonstrated an MD of −2.9848 (95% CI: −4.7965 to −1.1732), while monotherapy exhibited a non-significant MD of 0.9115 (95% CI: −3.5084 to 5.3314). TG analysis yielded a common effect size of 17.95, with a minimal-to-moderate heterogeneity (I2 = 0 to 84.7%).ConclusionProbiotics, particularly monotherapy for LDL and combination therapy for HDL, exhibited potential to improve lipid profiles in CHD patients. However, further research is needed to address existing limitations and confirm efficacy.https://www.frontiersin.org/articles/10.3389/fnut.2025.1612021/fullprobioticscoronary heart diseaseLDL cholesterolHDL cholesteroltriglycerides
spellingShingle Jie Dong
Lei Chen
Nan Zheng
Ming Yang
The beneficial effects of probiotics on patients with coronary heart disease: a systematic review and meta-analysis
Frontiers in Nutrition
probiotics
coronary heart disease
LDL cholesterol
HDL cholesterol
triglycerides
title The beneficial effects of probiotics on patients with coronary heart disease: a systematic review and meta-analysis
title_full The beneficial effects of probiotics on patients with coronary heart disease: a systematic review and meta-analysis
title_fullStr The beneficial effects of probiotics on patients with coronary heart disease: a systematic review and meta-analysis
title_full_unstemmed The beneficial effects of probiotics on patients with coronary heart disease: a systematic review and meta-analysis
title_short The beneficial effects of probiotics on patients with coronary heart disease: a systematic review and meta-analysis
title_sort beneficial effects of probiotics on patients with coronary heart disease a systematic review and meta analysis
topic probiotics
coronary heart disease
LDL cholesterol
HDL cholesterol
triglycerides
url https://www.frontiersin.org/articles/10.3389/fnut.2025.1612021/full
work_keys_str_mv AT jiedong thebeneficialeffectsofprobioticsonpatientswithcoronaryheartdiseaseasystematicreviewandmetaanalysis
AT leichen thebeneficialeffectsofprobioticsonpatientswithcoronaryheartdiseaseasystematicreviewandmetaanalysis
AT nanzheng thebeneficialeffectsofprobioticsonpatientswithcoronaryheartdiseaseasystematicreviewandmetaanalysis
AT mingyang thebeneficialeffectsofprobioticsonpatientswithcoronaryheartdiseaseasystematicreviewandmetaanalysis
AT jiedong beneficialeffectsofprobioticsonpatientswithcoronaryheartdiseaseasystematicreviewandmetaanalysis
AT leichen beneficialeffectsofprobioticsonpatientswithcoronaryheartdiseaseasystematicreviewandmetaanalysis
AT nanzheng beneficialeffectsofprobioticsonpatientswithcoronaryheartdiseaseasystematicreviewandmetaanalysis
AT mingyang beneficialeffectsofprobioticsonpatientswithcoronaryheartdiseaseasystematicreviewandmetaanalysis